Description

1-(m-Chlorophenyl)-3-(3-Morpholinopropylaminocarbonyl)-4-Methyl-1,4-Dihydropyrazolo[4,3-C][1,2]Benzothiazine 5,5-Dioxide is a high-purity, complex heterocyclic compound with significant potential in advanced pharmaceutical research and development. This molecule is valued for its intricate structure, which serves as a key pharmacophore in the design of novel therapeutic agents. It is primarily sought by research institutions and pharmaceutical companies engaged in the discovery and synthesis of new active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) and anti-inflammatory targets.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, especially for neurological and psychiatric disorders.
• Biochemical Research: Used as a reference standard or probe compound in pharmacological studies to investigate receptor binding and enzyme inhibition.
• Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies to optimize the efficacy and selectivity of lead compounds.
• API Development: Functions as a precursor in the multi-step synthesis of complex target molecules for preclinical and clinical development.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and scale-up services for the life sciences industry.

Basic Information

Product Name	1-(m-Chlorophenyl)-3-(3-Morpholinopropylaminocarbonyl)-4-Methyl-1,4-Dihydropyrazolo[4,3-C][1,2]Benzothiazine 5,5-Dioxide
CAS No.	81761-94-6
Molecular Formula	C24H25ClN4O4S
Molecular Weight	501.00 g/mol
Synonyms	1-(3-Chlorophenyl)-3-[[3-(4-morpholinyl)propyl]carbamoyl]-4-methyl-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide; 1-(m-Chlorophenyl)-3-(3-morpholinopropylcarbamoyl)-4-methyl-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide; 81761-94-6; UNII-6FQ6S8G1QH; 6FQ6S8G1QH; SCHEMBL218184; DTXSID40422323; CHEMBL3185264
EINECS	Contact for details

Quality Control

Our 1-(m-Chlorophenyl)-3-(3-Morpholinopropylaminocarbonyl)-4-Methyl-1,4-Dihydropyrazolo[4,3-C][1,2]Benzothiazine 5,5-Dioxide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, MS), to ensure it meets the high standards required for research and development. Certificates of Analysis (COA) with complete batch data are provided to guarantee traceability and consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed in a dry environment. For long-term storage, consider inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.